ALT
Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
Tuesday, August 19, 2025 1 min read
Key Takeaway: Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
Full Press Release Details
Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD).